TECENTRIQ SC

Google image searchProduct monograph

Active ingredient

atezolizumab, 125 MG/ML

DIN: 02546310

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 16-MAY-2024

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
• L01FF05 — ATEZOLIZUMAB (ATC/DDD)

External Links for Tecentriq Sc

Search on Google

• Tecentriq Sc side effects
• Tecentriq Sc dosage
• atezolizumab side effects
• atezolizumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find tecentriq sc photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.